HOME >> BIOLOGY >> NEWS
ISN's Nexus Hypertension-Kidney debate

The Infinite Gain: three decades on

Delivering the Opening Plenary Lecture, John E. Hall, Guyton Professor, Chairman of Physiology and Biophysics and Director of the Center of Excellence in Cardiovascular -Renal Research (University of Mississippi Medical Center), will present on Renal-Pressure Natriuresis - An Infinite Gain Feedback Mechanism fo Long-Term Blood Pressure Regulation"

The Nexus Plenaries to follow will aim to map the relevance of Guyton's pioneering work in both present and future contexts, spanning a wide range of timely and related topics:

Genomics: Hap Map Project (Aravinda Chakravarti, USA), Proteomics of Renal Exosomes (Mark Knepper, USA), Epidemiology: the Developmental Origins of Adult Disease (David JP Barker, UK), and Circadian control of genes, cells, and organs (Ueli Schibler, Switzerland).

Biomarkers, regultators and risk factors

In alignment with the unique Nexus format, the core program will incorporate three sessions dedicated to both the bench and the 'bedside' levels. Promoting a highly multidisciplnary approach, Hypertension and the Kidney will offer it series of three parallel sessions to deliver the cutting edge basic and clinical discovery aimed at researchers, physicians and clnicians respectively. Mirrored at both levels, the Baisc Science and Clinical Sessions will offer in-depth, rigorous updates on and around RAAS and Cardiovascular Risk, Proteinuria and Hypertension and Diuretics Revisited.

The translational sessions: the jewel in the Nexus crown

The three Translational Sessions - the key and final phase in closing the bench to bedside gap - are naturally offered to all participants. Set to signpost future directions and concrete solutions in research, patient treatment and care - the ultimate step toward addressing real day to day clinical challenges. These sessions will tackle: Guyton's Concept in 2007, Salt-Regulation Effec
'"/>

Contact: Amanda Wren
amanda.wren@isn-online.org
32-473-938-672
International Society of Nephrology
10-May-2007


Page: 1 2

Related biology news :

1. Prize winners announced at ISNs World Congress of Nephrology
2. Research ends debate over benefits of butterfly defenses
3. Lawyers and ethicists debate ashley treatment in open forum
4. Center for Science Writings debate: Redesigning Humanity, March 21
5. Scientists debate the neurobiological underpinnings of amnesia
6. Genome archaeology illuminates the genetic engineering debate
7. Math and fossils resolve a debate on dinosaur metabolism
8. Physics and biology team up to tackle protein folding debate
9. Researchers say environmental pollution is important piece of social justice debate
10. Different but equal: Settling the dosage compensation debate
11. Study continues the debate on the nature of bisexual men

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... Research and Markets has announced the addition of the "Biometric ... to their offering. ... The biometric vehicle access system market, in terms of value, ... to 2021. The market is estimated to be USD 442.7 Million ... The growth of the biometric vehicle access system market is fueled ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... ... January 12, 2017 , ... After her brain cancer ... gave her only a few months to live. Now a paper publishing January ... Rosendahl’s disease and increased both the quantity and quality of her life: Adding ...
(Date:1/12/2017)... and Pune, India , January 12, 2017 ... Market by Type and End Users - Global Opportunity Analysis and Industry Forecast, 2014-2022," ... 2022 from $2,921 million in 2015, growing at a CAGR of 15.07% during the ... ... Allied Market Research Logo ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical trial ... of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The ... percent of these heavily pretreated patients saw clinical benefit from the drug, with ...
(Date:1/11/2017)... ... January 11, 2017 , ... Photonics industry and STEM ... are commending the U.S. Congress and President Obama for their recognition of the ... the American Innovation and Competitiveness Act (AICA). , The language of the act ...
Breaking Biology Technology:
Cached News: